Onyx Healthcare (ROCO:6569) Piotroski F-Score: 5 (As of Jul. 12, 2026) — 17% Below Median


ROCO:6569 Onyx Healthcare Inc ROCO:6569
75 GF Score
Price NT$106.50
GF Value NT$121.39
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Onyx Healthcare Piotroski F-Score?

Onyx Healthcare ROCO:6569 75 Piotroski F-Score is 5 as of Jul. 12, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 54.75% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Onyx Healthcare has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Onyx Healthcare's Piotroski F-Score or its related term are showing as below:

ROCO:6569' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Onyx Healthcare was 8. The lowest was 3. And the median was 6.

Onyx Healthcare  (ROCO:6569) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Onyx Healthcare Piotroski F-Score Related Terms


Onyx Healthcare Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare Piotroski F-Score Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 6.00 6.00 4.00 5.00

Onyx Healthcare Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 4.00 5.00 5.00

ROCO:6569 vs VEEV, BTSG, TEM: Piotroski F-Score Comparison

For the Health Information Services subindustry, Onyx Healthcare's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onyx Healthcare Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Onyx Healthcare's Piotroski F-Score falls into.


ROCO:6569
75GF Score
Onyx Healthcare Inc ROCO:6569
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was 7.394 + 24.153 + 34.072 + 46.514 = NT$112 Mil.
Cash Flow from Operations was 42.701 + 24.564 + 66.189 + 28.33 = NT$162 Mil.
Revenue was 309.941 + 357.469 + 330.137 + 315.741 = NT$1,313 Mil.
Gross Profit was 92.506 + 124.677 + 99.684 + 117.15 = NT$434 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was
(2106.193 + 2105.171 + 2174.385 + 2119.794 + 2153.687) / 5 = NT$2131.846 Mil.
Total Assets at the begining of this year (Dec24) was NT$2,106 Mil.
Long-Term Debt & Capital Lease Obligation was NT$146 Mil.
Total Current Assets was NT$834 Mil.
Total Current Liabilities was NT$384 Mil.
Net Income was 50.808 + 38.499 + 26.789 + 64.818 = NT$181 Mil.

Revenue was 275.34 + 299.338 + 284.008 + 382.565 = NT$1,241 Mil.
Gross Profit was 114.042 + 104.983 + 88.936 + 148.314 = NT$456 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was
(2048.208 + 2211.472 + 2233.981 + 2094.093 + 2106.193) / 5 = NT$2138.7894 Mil.
Total Assets at the begining of last year (Dec23) was NT$2,048 Mil.
Long-Term Debt & Capital Lease Obligation was NT$157 Mil.
Total Current Assets was NT$825 Mil.
Total Current Liabilities was NT$339 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Onyx Healthcare's current Net Income (TTM) was 112. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Onyx Healthcare's current Cash Flow from Operations (TTM) was 162. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=112.133/2106.193
=0.05323966

ROA (Last Year)=Net Income/Total Assets (Dec23)
=180.914/2048.208
=0.08832794

Onyx Healthcare's return on assets of this year was 0.05323966. Onyx Healthcare's return on assets of last year was 0.08832794. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Onyx Healthcare's current Net Income (TTM) was 112. Onyx Healthcare's current Cash Flow from Operations (TTM) was 162. ==> 162 > 112 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=146.119/2131.846
=0.06854107

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=156.606/2138.7894
=0.0732218

Onyx Healthcare's gearing of this year was 0.06854107. Onyx Healthcare's gearing of last year was 0.0732218. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=834.041/384.249
=2.17057429

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=824.607/338.864
=2.43344528

Onyx Healthcare's current ratio of this year was 2.17057429. Onyx Healthcare's current ratio of last year was 2.43344528. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Onyx Healthcare's number of shares in issue this year was 39.375. Onyx Healthcare's number of shares in issue last year was 39.057. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=434.017/1313.288
=0.3304812

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=456.275/1241.251
=0.36759286

Onyx Healthcare's gross margin of this year was 0.3304812. Onyx Healthcare's gross margin of last year was 0.36759286. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=1313.288/2106.193
=0.6235364

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=1241.251/2048.208
=0.60601804

Onyx Healthcare's asset turnover of this year was 0.6235364. Onyx Healthcare's asset turnover of last year was 0.60601804. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Onyx Healthcare has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Onyx Healthcare (ROCO:6569) has a Piotroski F-Score of 5 as of Jul. 12, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Onyx Healthcare and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Onyx Healthcare's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Onyx Healthcare ranks #295 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 45.2%.
Is Onyx Healthcare's Piotroski F-Score too high?
Onyx Healthcare's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Onyx Healthcare's value of 5 is 0% at this industry median. Based on the distribution chart, Onyx Healthcare ranks #295 out of 652 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Piotroski F-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #295 out of 652 companies for Piotroski F-Score. This puts Onyx Healthcare in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Onyx Healthcare's value of 5 is 0% at this benchmark. Historically, Onyx Healthcare's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Onyx Healthcare has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Piotroski F-Score is 5 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
  • GF Score™: 75/100 with 7 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#295 of 652)

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score

Get the complete analysis for ROCO:6569

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$106.50
Price
NT$121.39
GF Value